These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 225521)

  • 1. Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.
    Leinbach SS; Summers WC
    J Virol; 1979 Apr; 30(1):248-54. PubMed ID: 225521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
    Takimoto T; Sato H; Ogura H
    Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Epstein-Barr virus (EBV) and human cell lines: growth and EBV induction.
    Takimoto T; Iwawaki J; Tanaka S; Umeda R
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(1):40-6. PubMed ID: 2154734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro.
    Steinitz M; Klein G
    Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3518-20. PubMed ID: 171663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible DNA-RNA tumor virus interaction in human lymphomas: expression of retroviral proteins in Ramos lymphoma lines is enhanced after conversion with Epstein-Barr virus.
    Lasky RD; Troy FA
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):33-7. PubMed ID: 6320170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
    Fresen KO; zur Hausen H
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between the amounts of EBV-DNA and EBNA per cell, clonability and tumorigenicity in two ebv-negative lymphoma lines and their EBV-converted sublines.
    Ernberg I; Klein G; Giovanella BC; Stehlin J; McCormick KJ; Andersson-Anvret M; Aman P; Killander D
    Int J Cancer; 1983 Feb; 31(2):163-9. PubMed ID: 6298125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of Epstein-Barr virus originating from P3HR-1 cells. I. Studies on EBNA induction.
    Fresen KO; Merkt B; Bornkamm GW; Hausen H
    Int J Cancer; 1977 Mar; 19(3):317-23. PubMed ID: 191406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-induced increase in the concanavalin-A receptor density of established EBV-negative lymphoma lines in vitro.
    Siegert W; Mönch T; Valet G
    Exp Hematol; 1980 Nov; 8(10):1173-82. PubMed ID: 6262102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
    Fresen KO; Hausen H
    Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogene expression in isogenic, EBV-positive and -negative Burkitt lymphoma cell lines.
    Glazer PM; Summers WC
    Intervirology; 1985; 23(2):82-9. PubMed ID: 2984143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
    Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA.
    Clements GB; Klein G; Povey S
    Int J Cancer; 1975 Jul; 16(1):125-33. PubMed ID: 170210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular size variation of EBNA is determined by the EB viral genome.
    Gergely L; Sternås L; Dillner J; Klein G
    Intervirology; 1984; 22(2):85-96. PubMed ID: 6090339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cytotoxicity of tumour promoter TPA for EBV-negative human lymphoma cell lines and their EBV-converted sublines.
    Béchet JM; Guétard D
    Int J Cancer; 1983 Jul; 32(1):61-5. PubMed ID: 6305854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    Rooney C; Howe JG; Speck SH; Miller G
    J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent herpes simplex virus infections established in two Burkitt lymphoma derived cell lines.
    Robey WG; Graham BJ; Harris CL; Madden MJ; Pearson GR; Vande Woude GF
    J Gen Virol; 1976 Jul; 32(1):51-62. PubMed ID: 182914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the protein composition of Epstein-Barr Virus-negative lymphoma cells after EBV-conversion.
    Siegert W; Mönch T
    Anticancer Res; 1983; 3(1):11-6. PubMed ID: 6299173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B cell line by Epstein-Barr virus.
    Lacy J; Summers WP; Summers WC
    EMBO J; 1989 Jul; 8(7):1973-80. PubMed ID: 2551670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.